Featured Research

from universities, journals, and other organizations

Cardiac CT Offers A Better, Cost-effective Approach To Diagnose Low-risk Chest Pain Patients

Date:
April 30, 2009
Source:
American Roentgen Ray Society
Summary:
Using cardiac CT to diagnose low risk patients with chest pain is significantly cheaper -- 44 percent less than the standard of care -- and can decrease the length of hospital stay up to 20 hours, according to a study performed at the University of Washington in Seattle, Wash.

Using cardiac CT to diagnose low risk patients with chest pain is significantly cheaper—44% less than the standard of care—and can decrease the length of hospital stay up to 20 hours, according to a study performed at the University of Washington in Seattle, WA.

Related Articles


Fifty three low-risk chest pain patients were compared by using results from a cardiac CT based workup and a traditional standard of care workup using nuclear stress testing. “Nothing was cut from the standard of care workup,” said Janet May, MS, lead author of the study. William Shuman, MD, worked with Janet on this study.

“The current emergency department standard of care workup for low risk chest pain patients often involves serial cardiac enzymes, serial ECGs and a nuclear cardiac stress test. Such a workup can take up to 30 hours and is expensive. The mean cost for the SOC workup in this study was $7,597,” said Janet. “With new lower dose cardiac CT options available that lower the patient radiation dose, patients get a faster evaluation and are discharged much sooner with a cardiac CT; in less than six hours,” she said.

“Once you know the case is a low risk patient with chest pain, the sooner the cardiac CT is done, the better. “Speed results in cost savings without compromising accuracy,” said Janet.

“Emergency rooms across the nation are struggling with congestion and escalating cost issues. Over six million patients present to US emergency rooms each year with chest pain and the majority of these are low risk. Dealing with these patients faster and with greater cost effectiveness is a big step toward ameliorating congestion and spiraling cost,” she said.

This study will be presented at the 2009 ARRS Annual Meeting in Boston, MA, on Monday, April 27.


Story Source:

The above story is based on materials provided by American Roentgen Ray Society. Note: Materials may be edited for content and length.


Cite This Page:

American Roentgen Ray Society. "Cardiac CT Offers A Better, Cost-effective Approach To Diagnose Low-risk Chest Pain Patients." ScienceDaily. ScienceDaily, 30 April 2009. <www.sciencedaily.com/releases/2009/04/090423132618.htm>.
American Roentgen Ray Society. (2009, April 30). Cardiac CT Offers A Better, Cost-effective Approach To Diagnose Low-risk Chest Pain Patients. ScienceDaily. Retrieved March 3, 2015 from www.sciencedaily.com/releases/2009/04/090423132618.htm
American Roentgen Ray Society. "Cardiac CT Offers A Better, Cost-effective Approach To Diagnose Low-risk Chest Pain Patients." ScienceDaily. www.sciencedaily.com/releases/2009/04/090423132618.htm (accessed March 3, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, March 3, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Treadmill Test Can Predict Chance Of Death Within A Decade

Treadmill Test Can Predict Chance Of Death Within A Decade

Newsy (Mar. 2, 2015) Johns Hopkins researchers analyzed 58,000 heart stress tests to come up with a formula that predicts a person&apos;s chances of dying in the next decade. Video provided by Newsy
Powered by NewsLook.com
Going Gluten-Free Could Get You A Tax Break

Going Gluten-Free Could Get You A Tax Break

Newsy (Mar. 2, 2015) If a doctor advises you to remove gluten from your diet, you could get a tax deduction on the amount you spend on gluten-free foods. Video provided by Newsy
Powered by NewsLook.com
GlaxoSmithKline and Novartis Try Swapping Success

GlaxoSmithKline and Novartis Try Swapping Success

Reuters - Business Video Online (Mar. 2, 2015) GlaxoSmithKline and Novartis have completed a series of asset swaps worth more than $20 billion. As Grace Pascoe reports they say the deal will reshape both drugmakers. Video provided by Reuters
Powered by NewsLook.com
How Can West Africa Rebuild After Ebola?

How Can West Africa Rebuild After Ebola?

Reuters - Business Video Online (Mar. 2, 2015) How best to rebuild the three West African countries struggling with Ebola will be discussed in Brussels this week. As Hayley Platt reports Sierra Leone has the toughest job ahead - its once thriving economy has been ravaged by the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins